Kozamod 5% Cream 12 Sachet

Product Description:

• Kozamod's mechanism of action is via stimulation of innate and acquired immune responses, which ultimately leads to inflammatory cell infiltration within the field of drug application followed by apoptosis of diseased tissue.


• Kozamod does not have direct antiviral activity.


• Kozamod is an immune response modifier that acts as a toll-like receptor 7 agonist.


• Kozamod is commonly used topically to treat warts on the skin of the genital and anal areas.


• Kozamod does not cure warts, and new warts may appear during treatment.


• Kozamod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production.


• It is not used on warts inside the vagina, penis, or rectum.


• Kozamod is also used to treat a skin condition of the face and scalp called actinic keratoses.


• Kozamod can also be used to treat certain types of skin cancer called superficial basal cell carcinoma.


• Kozamod is particularly useful on areas where surgery or other treatments may be difficult, complicated or otherwise undesirable, especially the face and lower legs.

kozamod Cream is used for the topical treatment of:

• Clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (AK) on face or scalp in immunocompetent adults.

kozamod is also used to associated treatment for these conditions:

• Actinic Keratoses of the face, Actinic Keratoses of the scalp, Condylomata Acuminata, Herpes Simplex Infection, Molluscum Contagiosum, Superficial Basal Cell Carcinoma

How To Use:

kozamod dosage

External Genital Warts (Egw):

• 3 times per week until total clearance or a maximum of 16 weeks.

• Kozamod Cream is not for oral, ophthalmic, or intravaginal use

Actinic Keratosis:

• 2 times per week for a full 16 weeks.

Superficial Basal Cell Carcinoma:

• 5 times per week for a full 6 weeks.

Warnings And Precautions:

• Intense local inflammatory reactions can occur (e.g., skin weeping, erosion).

Dosing interruption may be required:     

• Severe local inflammatory reactions of the female external genitalia can lead to severe vulvar swelling.


• Severe vulvar swelling can lead to urinary retention; dosing should be interrupted or discontinued.   


• Flu-like systemic signs and symptoms including malaise, fever, nausea, myalgias and rigors may occur. Dosing interruption may be required    


• Avoid exposure to sunlight and sunlamps. Wear sunscreen daily    


• Safety and efficacy have not been established for repeat courses of treatment to the same area for AK  


• Kozamod Cream is not recommended for treatment of BCC subtypes other than the superficial variant, i.e., sbcc    


• Treatment of urethral, intra-vaginal, cervical, rectal or intra-anal viral disease is not recommended.  


• Safety and efficacy in immunosuppressed patients have not been established.

Ingredients:

• Imiquimod 5%.

Product Details:

• Product Type: Sachets
• Manufacturer: Kozamod
• Product Form: Sachets